Our Blog​

Latest News

How AI Research Agents Are Transforming Life Sciences Intelligence

  In the high-stakes arena of drug development and clinical evidence generation, the bottleneck is no longer the availability of data; it is the speed of synthesis. For the past...

Webinar Recap: AI Agents and Patient-Level Data – From Confirmation of Diagnosis to Insights

AI research agents are no longer theoretical in rare disease and oncology—they’re starting to reshape how teams find patients, understand journeys, and generate evidence. That reality came through clearly in...

When Good Intentions Meet Bad Data: Why Pharma Patient Research Projects Go Off Track

Pharmaceutical companies invest billions to understand patients. Market research teams conduct thousands of surveys and collect patient-reported outcomes with the genuine intent of developing better therapies and launching products that...

Clinakos, Rare Disease, Integrated Patient Data, Medically Smart AI, Patient Registry, , Insights, Market Research, RWD, FDA

Why the FDA’s New Plausible Mechanism Pathway Demands a Data Revolution

FDA’s proposed Plausible Mechanism Pathway for bespoke therapies implicitly assumes a robust real‑world data (RWD) and real‑world evidence (RWE) ecosystem 1, even though the article only briefly names it in...